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Abstract
Background: Despite the reported high prevalence of osteoporosis in the human immunodeficiency virus
(HIV)-population, there have been no previous studies examining dairy calcium intake and bone mineral density
(BMD) in HIV-subjects.
We assessed the prevalence of low BMD in HIV-infected and uninfected subjects and analyzed the effects of
calcium intake, lifestyle and HIV-related risk factors on BMD.
Methods: One hundred and twelve HIV-infected subjects were consecutively enrolled. Seventy- six HIV-uninfected
subjects matched for age and sex were enrolled as the control group. The HIV-subjects were interviewed about
lifestyle habits and completed a weekly food-frequency questionnaire to estimate calcium intake. HIV-RNA, CD4+
T-cell count and data on antiretroviral therapy were also recorded. Both biochemical bone turnover markers and
BMD, assessed by dual-energy radiographic absorptiometry (DXA) were recorded in the HIV-cases and controls. We
also calculated the 10-year fracture risks using the WHO FRAX equation.
Results: Osteoporosis prevalence was significantly higher in the HIV-cases than controls (p < 0.05). BMI values were
positively correlated with BMD (p < 0.05). Vitamin D levels were lower in the HIV-subjects (p < 0.02). No correlation
was found with daily calcium intake.
BMI values were significantly correlated with dairy intake quartiles (p < 0.003). In HIV-subjects, the mean of FRAX
score was 1.2 % for hip and 4.7 % for major osteoporotic fractures. On multivariate analysis of the lumbar spine
DXA T-score, age (p < 0.005) and HIV/hepatitis C virus co-infection (p < 0.0001) were negatively correlated with
BMD, while yogurt intake was a protective predictor of BMD (p < 0.05). In the femur DXA T-score, age (p < 0.01),
nadir CD4 + T-cell count < 200 cells/μL (p < 0.05) and drug addiction ( p < 0.0001) were negatively correlated with
BMD.
Conclusions: Among the foods rich in calcium, yogurt was a protective predictor of BMD in HIV-subjects. HIV/HCV
co-infection, nadir CD4 + T-cell count < 200 cells/μL and drug addiction were independent predictors of severe
BMD. Promoting behavioral changes in food intake and lifestyle, aimed at the primary prevention of bone disease
in the chronically-infected subjects seems to be essential for implementing medical intervention in these cases.
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Background
Osteoporosis and its resulting fractures are becoming
major public health issues due to population ageing and
the world-wide increase in long-term chronic conditions
[1-3].
However, fractures in different populations considered
at low risk of osteoporosis and with low-normal bone
mineral density (BMD) have also been reported [4,5].
Low BMD has emerged as a significant problem in
chronically-infected patients, such as the HIV-infected
population [1-3]. The mechanisms by which risk factors
accelerate bone loss in human immunodeficiency virus
(HIV)-infected subjects are unclear because of their
complex and multifactorial nature [6]. The chronic in-
flammatory state induced by the virus itself may pro-
mote bone loss by increasing levels of pro-inflammatory
cytokines such as tumor necrosis factor-α (TNF-α), IL-6,
IL-1 and NF-kappaB-ligand (RANKL), a member of the
TNF superfamily of ligands and receptors [1,6]. Also
weight loss, hypoparathyroidism and vitamin D defi-
ciency resulting from HIV infection, as well as many
antiretroviral drugs, may promote bone loss [7].
In addition to the traditional risk factors (i.e. older age,
female sex, menopause, corticosteroid therapy, low BMI)
attention has recently been centered on the importance
of following a diet rich in calcium, other minerals and
vitamin D associated with physical activity, which is
recommended to maintain not only a healthy bone
structure but also an acceptable BMD [8].
Since general risk factors and HIV-related factors
affect both bone turnover and BMD, the aim of our
study was to assess the prevalence of low BMD in HIV-
infected subjects and controls and to analyze the effects
of calcium intake and other environmental risk factors
in order to increase current interest in the management
of bone disease in the HIV-population through appro-
priate dietary and lifestyle interventions. We also esti-
mated the 10-year fracture risk.
Methods
Study population
The study participants were Caucasian HIV-infected
patients, consecutively enrolled between January 2011
and January 2012, who were being followed-up prospect-
ively at the AIDS Center of the University of Palermo.
BMD was measured in all subjects by dual X-ray ab-
sorptiometry (DXA) [9]. Exclusion criteria included kid-
ney disease, gastrointestinal disorders and steroid and
sex steroid therapy.
Data on age, gender, drug addiction, antiretroviral
therapy (ART), protease inhibitors (PI) and non-
nucleoside reverse-transcriptase inhibitor (NNRTI) ex-
posure were all recorded in a database designed for this
study. Specific tenofovir exposure > 1 year was also
recorded. Exposures to ART and PI were graded 0 (no
exposure) to 3 (1: < five years; 2: from five to nine years;
3: ≥ ten years).
Body mass index (BMI) was calculated as weight (in
kg) divided by height squared (m2). Subjects were con-
sidered underweight when BMI was ≤ 18.5 kg/m2, nor-
mal weight when BMI was between 18.6-24.9 kg/m2,
overweight when BMI was between 25–29.9 kg/m2 and
obese when BMI was ≥ 30 kg/m2.
Diabetes mellitus was defined in accordance with the
Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus criteria [10].
Seventy-six HIV-uninfected subjects referred by family
doctors to our Center for laboratory and BMD assess-
ment were enrolled as the control group. Age and sex of
these subjects were comparable with the patients and
the same exclusion criteria were applied.
Interview data
At the start of the study, the HIV-infected subjects filled
in a health and lifestyle questionnaire considering med-
ical and drug abuse history, lifestyle habits (including
smoking status, alcohol consumption, Italian espresso
coffee drinking, physical activity) and bone fractures.
Smoking status was categorized as non-smokers, former
smokers and current smokers. Alcohol intake > 20 g per
day either at the time of the study or in the past as well
as Italian espresso coffee intake > 4 cups per day were
also recorded. Physical activity was defined as either
non-occupational or occupational when physical exercise
was performed during free time or at work, respectively.
Non-occupational physical activity was considered active
when > 2 sessions of 20 minutes per week were per-
formed. Occupational physical activity was defined as
heavy when manual work was carried out.
In order to assess calcium intake, the consumption of
foods representing the major sources of daily calcium in-
take in the Italian diet, such as typical Italian aged cheese
(i.e. Parmesan), ricotta cheese and yogurt was recorded in
a weekly food-frequency questionnaire, in accordance with
the tables of nutrient values issued by the Italian National
Institute of Nutrition [11-13]. This was administered
through an individual face to-face interview [11]. A fixed
range of food containers, i.e. a glass for milk and a cup for
yogurt, was used to standardize portion sizes, each con-
taining  300 mg of calcium. A similar amount of calcium
was contained in the reference servings of aged and ricotta
cheese ( 25 and 100 g, respectively). Color photographs
were shown to the subjects to demonstrate the standard
sizes of the cheese servings. In addition, the number of ser-
vings eaten weekly was recorded and calcium intake was
categorized according to quartiles of weekly servings (1:
≤8, 2: 9–10, 3: 11–14, and 4: ≥15), based on the distribu-
tion of the HIV-population. The level of education was
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also determined for all subjects. Three options were used:
primary school (which in Italy represents a five-year com-
pulsory education period), lower secondary school (three
additional compulsory years) and higher levels of educa-
tion, including upper secondary school, professional
schools or university.
Laboratory methods
In all the HIV-patients CD4+ T-cell count (most recent
value and nadir) and plasma HIV-RNA levels were
assessed as previously reported [14]. Serum bone alka-
line phosphatase, 25-hydroxyvitamin D, phosphorus and
calcium levels were obtained in both HIV -infected cases
and un-infected controls.
Vitamin D assessment was performed in the sunnier
months from April through October, since it is known that
vitamin D formation is not possible or inadequate [15] in
Italy during the less sunny months, due to its latitude.
Bone mineral density assessment
For both HIV-infected cases and uninfected controls,
BMD was assessed at baseline by DXA, using a QDR Dis-
covery Hologic DXA in the femoral neck and DXA in the
lumbar spine by total body DXA [16]. For each scan, BMD
and T-scores were recorded. T-scores compare BMD with
the mean of a healthy young (age 20–30 years) reference
population, matched for sex and race, and were expressed
as the number of standard deviations above or below the
reference mean. Osteopenia was defined when at least one
of the two DXA T-scores was less than −1. Osteoporosis
was diagnosed when either femoral neck or lumbar spine
DXA T-scores were less than −2.5, as recommended by
the World Health Organization (WHO) and the National
Osteoporosis Foundation [17-19].
We calculated the 10-year fracture risks according to
the standardized WHO FRAX equation, computed with
BMD (T-score) at the femoral neck [20].
Statistical analysis
Data were expressed as mean ± standard deviation when
distribution was Gaussian. Differences were calculated using
Student’s t-test. Otherwise, data were expressed as median
and range and analyzed with the Mann–Whitney U test.
Fisher’s exact and χ2 tests, Pearson’s correlation and Spear-
man's rank correlation were used where appropriate. Mul-
tiple logistic regression analysis was performed to estimate
the independence of the association between lumbar spine
and femoral neck T-scores as well as variables significant at
univariate analysis in the HIV-infected subjects. Variables
contributing significantly to fit the logistic equation were
then selected by a step-wise procedure. P < 0.05 was consid-
ered significant.
All analyses were performed using the SPSS software
package (version 16.0; Chicago, IL, USA).
The study protocol conformed to the ethical guidelines
of the 1975 Declaration of Helsinki.
The study was approved by the local Ethics Committee
and informed consent was obtained from all subjects.
Results
Characteristics of the HIV-infected population
The main characteristics of the 112 HIV-infected and
control subjects are shown in Table 1.
The average age of the recruited patients was 47 ± 9.7
years. Sixty-three individuals were male (56%). Among the
112 subjects, 28 (25%) were overweight, 6 (5%) were
underweight (BMI < 18.5) and 7 (6%) were obese. As
regards smoking status, drug addiction and Italian espresso
coffee drinking we found that half of the study subjects
regularly smoked cigarettes, one third drank coffee > 4
times a day and one third used cocaine and/or heroin.
About half of this population did physical activity in
their free time and had a higher level of education.
Concerning eating habits, the median daily calcium in-
take was 454 mg/die, range (96–1359). More than half
of the participants interviewed reported that they drank
a glass of milk in the morning, whereas yogurt intake
was less frequent. Parmesan cheese intake, according to
our definition, was reported in about 90% of subjects.
Most subjects were on ART (93%), seventy-five (67%) had
nadir CD4+ T-cell count < 200 (cells/μL) and 41 (36.6%)
were co-infected with hepatitis C virus (HCV) (Table 1).
Prevalence of osteopenia and osteoporosis in HIV-
infected and uninfected subjects
Osteopenia was present in 38 (34%) HIV-infected vs 19
(25%) HIV-uninfected subjects (p = ns). In detail, at the
lumbar site osteopenia was present in 37 (33%) HIV-
infected vs 17 (22%) HIV-uninfected subjects (p < 0.02); at
the femoral site osteopenia was present in 42 (37.5%) HIV-
infected vs 18 (24%) HIV-uninfected subjects (p = ns). In
the setting of HIV-infection, osteopenia was present in 18
subjects at both the lumbar and femoral sites.
Osteoporosis was present in 34 (30.3%) HIV-infected
vs 8 (10%) HIV-uninfected subjects (p < 0.05). At the
lumbar site osteoporosis was present in 34 (30%) HIV-
infected vs 8 (10%) HIV-uninfected subjects (p < 0.05); at
the femoral site osteoporosis was present in 9 (8%) HIV-
infected vs 4 (5%) HIV-uninfected subjects (p = ns).
In the setting of HIV-infection osteoporosis was present
in 9 subjects at both the lumbar and femoral sites.
Comparison between lumbar spine and femoral neck
DXA T-scores and biochemical parameters in HIV-infected
and uninfected subjects
Lumbar spine DXA T-score were significantly lower in
HIV-infected (−1.4 range −5.2 to 1.6) than in uninfected
subjects (−1 range −4.4 to 2.7) (p < 0.02). No significant
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difference was found in femoral neck DXA T-score in
patients with or without HIV-infection (data not shown).
Serum bone alkaline phosphatase was significantly
higher in HIV-infected (54.7 range 19–170 IU/L) than
uninfected subjects (28.2 range 5–84 IU/L) (p < 0.0001),
while phosphorus levels were lower in HIV-infected (3.1
range 1.4-4.4 mg/dL) than in uninfected subjects (3.5
range 2.1-6.8 mg/dL) (p < 0.0001). 25-hydroxyvitamin D
levels were also lower in HIV-subjects (16.4 range 0.7-
74 ng/mL) than in controls (20 range 9–40.2 ng/mL)
(p < 0.02).
Calcium and parathyroid hormone levels were not sig-
nificantly different in the two groups of patients (data
not shown).
Correlation between lumbar spine and femoral neck DXA
T-scores with demographic and environmental risk
factors and calcium intake in HIV-infected subjects
The correlations between the studied risk factors and lum-
bar spine and femoral neck DXAT-scores are presented in
Table 2. Age was negatively correlated with BMD mea-
sured in both the lumbar spine and femoral neck
(p<0.05). Higher BMI values were positively correlated
with BMD values measured in the femoral neck (p< 0.05).
No correlation was found between daily calcium intake
(specifically milk), Parmesan, weekly consumption or
quartile calcium intake and BMD measured in either the
lumbar spine or femoral neck. Yogurt intake was posi-
tively correlated with BMD measured in the lumbar
spine (p < 0.04).
By stratifying patients into two groups (milk or milk +
yogurt) we found that osteopenia and osteoporosis were
significantly higher in the patients with milk only than
in those with milk + yogurt (χMH=
2 5.6; p < 0.02).
As regards biochemical markers, increasing values of
bone alkaline phosphatase were negatively correlated
with lumbar spine and femoral neck DXA T-scores
(p < 0.002; p < 0.005, respectively).
Correlation between lumbar spine and femoral neck DXA
T-scores and characteristics of HIV- infection
Duration of HIV-infection was negatively correlated with
BMD in the femoral neck (p < 0.01). BMD in both lum-
bar spine and femoral neck DXA T-scores was negatively
correlated with drug addiction (p < 0.04; p < 0.02, re-
spectively), nadir CD4+ T-cell count < 200 (cells/μL)
(p < 0.05; p < 0.04, respectively), ART exposure score
(p < 0.002; p < 0.0001, respectively), PI exposure score
(p < 0.05; p < 0.001, respectively) and HCV co-infection
(p < 0.001; p < 0.005, respectively) (Table 2).
The mean of the 10-year risk of fracture, calculated in
76 HIV-infected subjects, was 1.2% for hip fracture and
4.7% for major osteoporotic fracture.
Figure 1 shows the positive correlation between BMI
values and quartiles of dairy intake (ρ= 0.36; p < 0.0001).
Lower dairy intake quartiles were more frequent in sub-
jects with osteoporosis than without, although the differ-
ence was not significant (ρ=−0.17; p=ns).
Table 1 Main characteristics of the 112 HIV-infected and
76 HIV-uninfected subjects
HIV+ HIV-
Demographic and lifestyle characteristics
Age years ± SD 47 ± 9.7 49 ± 11.3
Sex (M/F) 63/49 42/34
BMI (kg/m2):
< 25 77 (68.7) 47 (62)
≥ 25-29 28 (25) 23 (30)
≥ 30 7 (6.2) 6 (8)
Smoking status: 37 (33)
Non- smokers 44 (58)
Smokers 58 (53) 21 (28)
Former smokers 16 (14) 11 (14)
Free time physical activity 57 (51) 45 (60)
Heavy workers 16 (14) 10 (13)
Italian espresso caffeine intake1 30 (27) 23 (29)
Alcohol 6 (5) 3 (4)
Diabetes 20 (18) 11 (14)
Education:
Primary school 34 (30.3) 20 (26)
Secondary school 34 (30.3) 26 (34)
Higher level 44 (39.3) 30 (40)
Postmenopause 18 (36.7) 26 (34)
Fracture 4 (3.5) 2 (3)
Calcium intake
Daily calcium intake (mg/day) (range) 454 (96-1359)
Dairy intake (times/week) (range) 10 (2-32)
Daily milk intake (ml/day) (range) 200 (0-800)
Yogurt intake 36 (32)
Yogurt intake (ml/week) 0 (0-1750)
Parmesan intake 100 (89)
Characteristics of HIV infection
Time since HIV diagnosis (years) (range) 15 (1-27)
Drug addiction 28 (25)
CD4+ T-cell count (cells/μL) (range) 551 (5-1082)
nadir CD4+ T-cell count <200 (cells/μL) 75 (67)
Undetectable HIV-RNA 81 (72.3)
ART 104 (93)
Duration of ART exposure:
< 5 years 18 (17.3)
5-9 17 (16.3)
≥ 10 69 (66.3)
HCV infection 41 (36.6)
1 Italian espresso caffeine intake => 4 cups per day.
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Table 2 Correlation between lumbar spine, femoral neck DXA T-scores and the studied parameters in the HIV-infected
patients
Lumbar spine DXA T-score
n = 112
P < Femoral neck DXA T-score
n = 112
P <
DEMOGRAPHIC AND LIFESTYLE CHARACTERISTICS
Age a -0.20 0.05 -0.19 0.05
Female sex b 0.05 ns 0.07 ns
BMI (kg/m2) a 0.07 ns 0.11 ns
BMI score b,1 0.14 ns 0.20 0.05
Smoking status b,2 -0.01 ns 0.09 ns
Free time physical activity b 0.14 ns 0.06 ns
Heavy workersb 0.02 ns 0.04 ns
Italian espresso caffeine intake b,3 -0.04 ns -0.05 ns
Alcoholb -0.03 ns 0.02 ns
Diabetesb -0.14 ns -0.02 ns
Postmenopauseb -0.17 ns -0.17 ns
Fractureb -0.05 ns 0.17 ns
CALCIUM INTAKE
Daily calcium intake (mg/day)a 0.09 ns 0.05 ns
Dairy intake (times/week) a 0.09 ns 0.05 ns
Daily milk intake (ml/day)a 0.07 ns 0.08 ns
Parmesan intakeb 0.08 ns 0.15 ns
Yogurt intake (ml/week)b 0.23 0.04 0.11 ns
Dairy quartile intake (times /week)b,4 0.05 ns 0.04 ns
BIOCHEMICAL PARAMETERS
Calcium (mg/dL)a 0.12 ns 0.08 ns
Phosphorus (mg/dL)a 0.09 ns 0.13 ns
Parathyroid hormone (pg/mL)a -0.16 ns -0.13 ns
25-Hydroxyvitamin D (ng/mL)a -0.05 ns -0.08 ns
Bone alkaline phosphatase (IU/L)a -0.34 0.002 -0.32 0.005
CHARACTERISTICS OF HIV INFECTION
Drug addictionb -0.19 0.05 -0.25 0.02
CD4+ T-cell count (cells/μL)a 0.09 ns 0.12 ns
Nadir CD4+ <200 (cells/μL)b -0.22 0.05 -0.23 0.04
Undetectable HIV-RNAb 0.07 ns 0.09 ns
Time since HIV diagnosisa -0.17 ns -0.25 0.01
Score of ART exposureb,5 -0.23 0.002 -0.34 0.0001
Score of PI exposureb,5 -0.20 0.05 -0.32 0.001
Duration tenofovir exposure > 1 yearb -0.12 ns -0.11 ns
NNRTI exposureb -0.01 ns -0.01 ns
HCV infectionb -0.30 0.001 -0.27 0.005
Duration tenofovir exposure > 1 yearb -0.12 ns -0.11 ns
NNRTI exposureb -0.01 ns -0.01 ns
HCV infectionb -0.30 0.001 -0.27 0.005
a: Pearson’s correlation test; b: Spearman’s rank correlation test.
1 BMI score = 1: < 25; 2: ≥ 25–29; 3: ≥ 30 (kg/m2).
2 Smoking habits were graded 1: non- smokers, 2 smokers, 3 former smokers.
3 Italian espresso caffeine intake => 4 cups per day.
4 Dairy quartile intake (times /week) = 1: ≤8, 2: 9–10, 3: 11–14, and 4: ≥15.
5 ART and PI score = 0: no exposure; 1: < 5; 2: 5–9; 3: ≥ 10 years.
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No correlations between calcium intake and overall
fracture risk at 10 years (r =−0.12; p=ns) and between
calcium intake and risk of hip fracture at 10 years were
found (r =−0.13; p=ns).
At multiple linear regression analysis, age and HIV/
HCV co-infection were negatively correlated with
BMD measured in the lumbar spine (p < 0.0001;
p < 0.005, respectively), while an independent positive
correlation was found between yogurt intake and
BMD in the same site (p < 0.05). In the femoral neck
T-score, age, nadir CD4+ T-cell count < 200 (cells/μL)
and drug addiction (p < 0.01; p < 0.05; p < 0.0001, re-
spectively) were negatively correlated with BMD
(Table 3).
Discussion
To our knowledge, this is the first investigation on cal-
cium intake and its relationship with BMD in adult sub-
jects with HIV-infection. Previous studies in this area
focused on calcium intake and its potential metabolic
impact in HIV-subjects, or on its link with BMD in the
subset of a HIV- pediatric population [21-23]. Despite
the typical southern Italian regional habit of drinking a
glass of milk with coffee in the morning (about 300 mg
of calcium), median daily calcium intake in our HIV-
infected subjects was lower than the recommended daily
amount, as reported by other Asian and European stud-
ies [24-26]. Milk is a good source of both calcium and
vitamin D but other calcium-rich foods are needed to
create a balanced diet assuring sufficient calcium and
vitamin D intake in an HIV-population.
Parmesan cheese could be included in the "Mediterra-
nean diet group" of foods because it is usually added to
pasta and pizza. In fact, in our study interview Parmesan
(25 g = 300 mg calcium) was regularly consumed in 90%
of the HIV-subjects.
Among the various dairy foods available we considered
yogurt, which contains live active cultures and a sub-
stantial amount of calcium and vitamin D. Interestingly,
we found that weekly yogurt intake was a protective in-
dependent predictor of BMD in the lumbar spine.
When the patients were divided into two groups the
analysis showed a more favorable relationship between
yogurt plus milk and BMD than milk alone. No previous
study has examined the relationship between yogurt in-
take and BMD in HIV-infected subjects and only Sahni
et al. [27] showed that milk and high yogurt intake were
positively associated with hip and spine BMD in im-
munocompetent subjects in the Framingham Offspring
Study.
Figure 1 Correlation between BMI and dairy intake quartiles (times/week). The figure shows the significant Spearman’s correlation between
BMI values and dairy intake quartiles (1: ≤8, 2: 9–10, 3: 11–14, and 4: ≥15) in the HIV-infected subjects (ρ= 0.36; P< 0.0001).
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Probiotic microorganisms have considerable immuno-
modulatory effects in the gut-associated lymphoid tissue
[28]. The importance of the gut microbiota for the de-
velopment of the host’s immune system and the sug-
gested connection between gut microbiota and bone
mass in mice led the researchers to investigate the im-
pact of probiotic yogurt on bone mass, especially in the
HIV- population [29]. Further studies are required to
evaluate the gut microbiota and other micronutrients as
a novel therapeutic target for osteoporosis [30].
In the present study the prevalence of osteoporosis was
significantly higher in HIV- infected than in uninfected
subjects, a result similar to previous meta-analyses [31].
Currently, more intensive investigations have been
made to better understand whether HIV infection per se
is a risk factor for low BMD [1,7]. Since the virus itself
may induce hypovitaminosis D through many mechan-
isms (increased levels of TNF-α, inhibition of renal hy-
droxylation and induction of 25-hydroxyvitamin D
consumption by the macrophages and lymphocytes)
[7,32,33], the abnormal biochemical features found in
our HIV-infected subjects compared with the controls,
in particular the lower vitamin D levels, may support the
hypothesis that HIV per se might play a role in the
pathogenesis of bone loss. In addition, this finding in a
sunny country like Italy might suggest the need to de-
velop and recommend new key steps of calcium and
vitamin D intake in the prevention of osteoporosis.
Several HIV-related factors were correlated with BMD
on univariate analysis in both the lumbar spine and fem-
oral neck in our HIV-infected subjects. The correlation
between time of HIV diagnosis and BMD in the femoral
neck as well as nadir CD4+ T-cell count < 200 cells/μL
and BMD in both the lumbar spine and femoral neck and
the finding that nadir CD4+ T-cell count < 200 cells/μL
was an independent predictor of low BMD, suggest that
HIV infection per se and in particular the more advanced
stages of the disease might affect the skeletal system. This
finding also suggests that an earlier commencement of
ART might have a beneficial effect on BMD.
On the other hand, we found a significant negative
correlation between longer duration of ART, especially
PI exposure, and both lumbar spine and femoral neck
BMD on univariate analysis.
How to strike a balance between the various aspects to
be considered when providing ART, (such as when treat-
ment should be commenced or the classes of drugs to
be used, its influence on the progression of HIV disease
and, in the present case, its effects on BMD) in order to
maximize its benefits is an ongoing debate. In this re-
spect, while Grund et al. [34] showed that BMD con-
tinuously declined in a HIV-group receiving continuous
ART, Bolland et al. [35] found no evidence of accelerated
bone loss over 6 years in middle-aged HIV-infected men
treated with ART [36]. Many studies on the influence of
ART have shown that the relative risk of low BMD is
greater when PI are used [31,37-39], in agreement with
our results. Unfortunately, we were unable to evaluate
which drugs of the PI class were responsible for the low
BMD, whereas other authors have shown that indinavir
inhibits bone formation and lopinavir/ritonavir and ata-
zanavir/ritonavir are associated with BMD loss [31,39].
We did not find a significant correlation between
tenofovir exposure > 1 year and BMD in HIV-subjects,
unlike previous reports [39,40]. Recent data showed
that the introduction of tenofovir or emtricitabine/
tenofovir was associated with a 0.8 %–1.1 % decrease
in BMD which occurred mainly within the first year in
high-risk HIV-infected individuals [41]. In our study
the small number of enrolled HIV subjects and the
long exposure to different antiretroviral drugs made it
difficult to show the real impact of tenofovir exposure
on BMD health.
Moreover, no significant correlation was found be-
tween the small number of fractures reported in our
HIV- subjects and BMD at either of the sites. In a recent
Italian study, metabolic factors such as BMI and diabetes
mellitus were independently correlated with vertebral
fractures in HIV-infected patients [42]. Although low
BMD in the setting of HIV-infection is frequently





β-coefficient P < β-coefficient P <
HIV/HCV co-infection −1.3 0.0001 _
Age −0.48 0.005 −0.48 0.01
Yogurt intake 0.3 0.05 _
nadir CD4+ T-cell count < 200 (cells/μL) _ −0.32 0.05
Drug addiction _ −1.4 0.0001
a Variables excluded from the model for lumbar spine DXA T-score assessment: bone alkaline phosphatase, drug addiction , time since HIV diagnosis, score of ART
and PI exposure.
b Variables excluded from the model for femoral neck DXA T-score assessment: BMI score, Bone alkaline phosphatase, time since HIV diagnosis, score of ART and
PI exposure, HIV/HCV co-infection.
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observed, data on its relationship with fracture rate are
still under investigation [43].
To improve the ability to predict subsequent fragility
fracture in our patients, we used the WHO FRAX equa-
tion [20]. Although fracture risk at ten years and calcium
intake showed an inverse relationship this was not statis-
tically significant. However, the role of the FRAX score
in the HIV-population is still under debate because the
HIV-independent risk factors, HIV-related parameters
and ART characteristics were not evaluated by the score
itself [44].
Similar to other studies on enrolled HIV-infected sub-
jects with a long duration of infection, we found that
older age and BMI values had a negative or positive cor-
relation with BMD, respectively [45-47]. In this respect,
a meta-analysis on ten studies showed that low BMI was
the main factor behind the lower BMD values in HIV-
infected than in normal uninfected individuals [47].
The results regarding the relationship between dairy
product consumption and BMI are contradictory [48].
However, some cross-sectional data suggest that lower-
fat dairy products such as milk and yogurt are associated
with lower adiposity [48]. The positive correlation be-
tween higher BMI values and BMD in the femoral neck
DXA T-score or the increasing quartiles of calcium in-
take, suggest a protective role for calcium intake in the
prevention of BMD loss in our HIV-subjects [49]. This
observation may also encourage physicians to recom-
mend an increase in calcium consumption especially in
HIV-subjects with low BMD.
However, the ideal daily calcium intake to prevent
osteoporosis in HIV-positive subjects is not clear be-
cause it depends not only on known general and envir-
onmental risk factors but also on the patient’s long-term
immuno-virological course.
For most people, a daily calcium intake of between
1000 and 1300 mg is both safe and potent but we
hypothesize that the dose should be reviewed in relation
to ART and HIV-status.
Recent data have suggested that patients with AIDS
and addicted to heroin might be at particular risk for
bone loss [50]. The independent negative correlation
found between drug addiction and low BMD in our HIV
subjects confirms this finding.
Another interesting result emerging from our study is
the independent correlation between HIV/HCV co-
infection and BMD.
Vitamin D deficiency was found in HIV/HCV co-
infected patients [51]. Moreover, higher vitamin D levels
were independently associated with a rapid virological
response in patients with genotype 1 chronic hepatitis C
[52]. Increasing vitamin D intake may positively modu-
late the response to antiviral treatment in HCV-infected
or HIV/HCV co-infected patients. Further research is
necessary to better understand the impact of viral hepa-
titis on BMD in HIV-infected and uninfected subjects
and discuss the clinical applications and future direction
of this field [53].
Conclusions
To our knowledge, this is the only study to date to
evaluate calcium intake and low BMD in HIV-infected
subjects. Two interesting findings emerge from our
study, firstly, among the foods rich in calcium yogurt
was an independent protective predictor of BMD in
HIV-subjects; second, HIV/HCV co-infection, drug ad-
diction and nadir CD4+ T-cell count < 200 cells/μL were
independent predictors of severe bone disease. It seems
essential to implement medical treatment by promoting
behavioral changes in food intake and lifestyle in the pri-
mary prevention of bone disease in chronically-infected
people.
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